When in April 2021, Emergent BioSolutions ruined 15 million Johnson & Johnson COVID-19 vaccines due to quality-control mishaps at its poorly managed Baltimore production facility, Congress launched an investigation into whether Emergent used high-level connections to get billions of dollars in federal contracts despite a history of failing to deliver satisfactorily on its contracts.132 Congressional investigators also raised concerns about Emergent’s inadequate staff training, persistent quality-control issues, and the company stiffing the government with an “unjustified” 800 percent price
...more

